Trial Profile
Safety and efficacy study of the everolimus-eluting bioresorbable scaffold (BVS) in patients with ST-segment elevation myocardial infarction (STEMI)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- 17 Dec 2015 New trial record